A detailed history of Tidemark, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Tidemark, LLC holds 700 shares of PACB stock, worth $1,260. This represents 0.0% of its overall portfolio holdings.

Number of Shares
700
Previous 741 5.53%
Holding current value
$1,260
Previous $1.02 Million 99.9%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$1.2 - $2.17 $49 - $88
-41 Reduced 5.53%
700 $1,000
Q4 2023

Feb 09, 2024

BUY
$5.97 - $10.36 $4,423 - $7,676
741 New
741 $7.27 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $405M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Tidemark, LLC Portfolio

Follow Tidemark, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tidemark, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tidemark, LLC with notifications on news.